Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Phase 3 crawled time : 12:01 save search
Rockwell Medical Announces Dosing of First Patient in Pivotal Triferic® Phase 3 Trial by Partner, Wanbang Biopharmaceuticals, in China
Published: 2021-01-13 (Crawled : 12:01) - globenewswire.com
RMTI | $1.51 -5.63% -5.96% 110K
|
Health Technology
|
| O: 0.0%
H: 10.17%
C: 5.93%
china biopharma phase 3 trial
FibroGen Advances Phase 3 Clinical Development of Pamrevlumab for the Treatment of Idiopathic Pulmonary Fibrosis with Initiation of ZEPHYRUS-2
Published: 2020-12-22 (Crawled : 12:01) - globenewswire.com
FGEN | $1.3 -4.41% -4.62% 1.3M
|
Health Technology
|
| O: 0.67%
H: 1.22%
C: 0.42%
phase 3 treatment fibrosis
BioCryst Announces Positive Phase 1 Results with BCX9250, an Oral ALK-2 Inhibitor for Treatment of Fibrodysplasia Ossificans Progressiva
Published: 2020-12-21 (Crawled : 12:01) - globenewswire.com
BCRX | $4.68 -1.89% -1.92% 2.5M
|
Health Technology
|
| O: 0.58%
H: 0.75%
C: -4.16%
results positive treatment phase 3 phase 1 phase 2
Metacrine Reports Positive Results from Phase 1 Trial of MET642
Published: 2020-12-17 (Crawled : 12:01) - globenewswire.com
MTCR | $0.5814 -5.14% 84K
|
Health Technology
|
| O: 4.18%
H: 2.64%
C: -5.19%
results positive results positive trial phase 3 phase 1 phase 2 met642
FibroGen to Present Safety and Efficacy Analyses from Roxadustat Global Phase 3 Program at American Society of Hematology Annual Meeting
Published: 2020-12-02 (Crawled : 12:01) - globenewswire.com
FGEN | $1.3 -4.41% -4.62% 1.3M
|
Health Technology
|
| O: -0.32%
H: 3.62%
C: 2.15%
phase 3
Gainers vs Losers
| 49% | 51% |
Top 10 Gainers
KAVL | $6.275 135.02% 57.45% 44M
|
Wholesale Trade
PXMD | $0.7375 79.09% 44.16% 4.5M
|
Health Technology
DYNT | $0.371 -5.12% 43.09% 3.3M
|
Health Technology
LGVN P 3 d | $2.94 73.96% 42.52% 57M
|
HUBC | $1.94 49.23% 32.99% 73M
|
n/a
SPCB | $0.4044 46.52% 31.75% 130M
|
Electronic Technology
ONVO | $1.34 32.66% 24.62% 54M
|
Health Technology
OMQS | $0.6869 32.1% 24.3% 3.6M
|
Professional, Scientific, and T...
SNPO | $10.555 29.67% 22.88% 4M
|
AMBI | $3.72 -26.77% 21.77% 9.8K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.